Search PubMedSearch

PubMed · 42026183

Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome.

Loes M E Moolhuijsen·Jia Zhu·Benjamin H Mullin·Natàlia Pujol-Gualdo·Ky'Era V Actkins·Jasmine A Mack·Hridya Rao·Bhavi Trivedi·Katherine A Kentistou·Yajie Zhao·David Westergaard·Jaakko S Tyrmi·Gudmar Thorleifsson·Yanfei Zhang·Laura Wittemans·Amber DeVries·Kelly Brewer·Ryan Sisk·Rebecca Danning·Michael H Preuss·Michelle R Jones·Katherine S Ruth·Marianne Andersen·Ricardo Azziz·Karina Banasik·Michael Boehnke·Linda Broer·Søren Brunak·Yee-Ming Chan·Daniel I Chasman·Mark Daly·David A Ehrmann·Bart C Fauser·Lars G Fritsche·M Geoffrey Hayes·Chunyan He·Hongyan Huang·Irina Kowalska·Peter Kraft·Richard S Legro·Nan Lin·Ruth J Loos·Yvonne V Louwers·Reedik Magi·Mark I McCarthy·Laure Morin-Papunen·Jean V Morrison·Cynthia Morton·Girish N Nadkarni·Benjamin M Neale·Henriette Svarre Nielsen·Mette Nyegaard·Sisse R Ostrowski·Ole B V Pedersen·Erik Sørensen·Christina Mikkelsen·Christian Erikstrup·Kathrine A Kaspersen·Mie T Bruun·Bitten Aagaard·Henrik Ullum·Barbara Obermayer-Pietsch·Aarno Palotie·Mary P Reeve·Andres Salumets·Richa Saxena·Timothy D Spector·Bronwyn G A Stuckey·Unnur Thorsteinsdottir·André G Uitterlinden·Margrit Urbanek·Sebastian Zöllner·Genes and Health Research Team·DBDS Genomic Consortium·23andMe Research Team·David A van Heel·Joel N Hirschhorn·Kari Stefansson·John R B Perry·Unnur Styrkarsdottir·Scott G Wilson·Terhi Piltonen·Triin Laisk·Marjo-Riitta Jarvelin·Kharis Burns·Anne E Justice·Hannele Laivuori·Ken K Ong·Mark O Goodarzi·Lea K Davis·Andrea Dunaif·Cecilia M Lindgren·Joop S E Laven·Stephen Franks·Jenny A Visser·Corrine K Welt·Tugce Karaderi·Felix R Day

Abstract

Polycystic ovary syndrome (PCOS) and its underlying features remain poorly understood. In this genetic study (n = 544,513), we expand the number of genetic loci from 16 to 29, and additionally identify 31 associated plasma proteins. Many risk-increasing loci were associated with later age at menopause, underscoring the reproductive longevity related to an increased oocyte number and/or availability across the lifespan. Hormonal regulation in the etiology of this condition, through metabolic and reproductive features, was emphasized. The proteomic analysis highlighted metabolic biology known to be related to PCOS. A polygenic risk score (PRS) was associated with adverse cardiometabolic outcomes, with differing relevance of testosterone and body mass index in women and men. Finally, while oligo-anovulation and anovulatory infertility are features of PCOS, we observed no impact of PCOS susceptibility on childlessness. We suggest that PCOS susceptibility confers balanced pleiotropic influences on fertility in women, and life-long adverse metabolic consequences in both sexes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Loes M E Moolhuijsen, Jia Zhu, Benjamin H Mullin, Natàlia Pujol-Gualdo, Ky'Era V Actkins, Jasmine A Mack, Hridya Rao, Bhavi Trivedi, Katherine A Kentistou, Yajie Zhao, David Westergaard, Jaakko S Tyrmi, Gudmar Thorleifsson, Yanfei Zhang, Laura Wittemans, Amber DeVries, Kelly Brewer, Ryan Sisk, Rebecca Danning, Michael H Preuss, Michelle R Jones, Katherine S Ruth, Marianne Andersen, Ricardo Azziz, Karina Banasik, Michael Boehnke, Linda Broer, Søren Brunak, Yee-Ming Chan, Daniel I Chasman, Mark Daly, David A Ehrmann, Bart C Fauser, Lars G Fritsche, M Geoffrey Hayes, Chunyan He, Hongyan Huang, Irina Kowalska, Peter Kraft, Richard S Legro, Nan Lin, Ruth J Loos, Yvonne V Louwers, Reedik Magi, Mark I McCarthy, Laure Morin-Papunen, Jean V Morrison, Cynthia Morton, Girish N Nadkarni, Benjamin M Neale, Henriette Svarre Nielsen, Mette Nyegaard, Sisse R Ostrowski, Ole B V Pedersen, Erik Sørensen, Christina Mikkelsen, Christian Erikstrup, Kathrine A Kaspersen, Mie T Bruun, Bitten Aagaard, Henrik Ullum, Barbara Obermayer-Pietsch, Aarno Palotie, Mary P Reeve, Andres Salumets, Richa Saxena, Timothy D Spector, Bronwyn G A Stuckey, Unnur Thorsteinsdottir, André G Uitterlinden, Margrit Urbanek, Sebastian Zöllner, Genes and Health Research Team, DBDS Genomic Consortium, 23andMe Research Team, David A van Heel, Joel N Hirschhorn, Kari Stefansson, John R B Perry, Unnur Styrkarsdottir, Scott G Wilson, Terhi Piltonen, Triin Laisk, Marjo-Riitta Jarvelin, Kharis Burns, Anne E Justice, Hannele Laivuori, Ken K Ong, Mark O Goodarzi, Lea K Davis, Andrea Dunaif, Cecilia M Lindgren, Joop S E Laven, Stephen Franks, Jenny A Visser, Corrine K Welt, Tugce Karaderi, Felix R Day. 2026-04-23. Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome.. https://doi.org/10.1038/s41588-026-02543-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans